Recall of IMMULITE 2500 IGF-I (An in vitro diagnostic medical device (IVD))

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Siemens Ltd Diagnostics Division.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Risk Class
    Class II
  • Event Initiated Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    Siemens confirm a negative bias in patient medians of approximately 5 to 20% using the igf-i assay as compared to the reference range medians provided in the igf-i instructions for use (ifu) with kit lots released august 2008 through july 2011.
  • Action
    Laboratories to implement the work-around provided by the sponsor. A review of previously reported results should be considered.


  • Model / Serial
    IMMULITE 2500 IGF-I (An in vitro diagnostic medical device (IVD))Catalogue Number: L5KGF2Siemens Material Number: 10381367Lot Numbers: 189 - 227ARTG Number: 179720
  • Manufacturer


  • Manufacturer Parent Company (2017)
  • Source